Public A ttitudes T oward P articipation i n C ancer C linical Trials

LINICAL TRIALS are essential for the identification of effective therapies in modern medicine. The combination of earlier detection of virtually all forms of cancer and the application of new treatments developed through clinical trials has been responsible for the improvement in the 5-year survival

[1]  P. Butow,et al.  Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. Gandara,et al.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Burnett Cb,et al.  Factors that influence a patient's decision to participate in a phase I cancer clinical trial. , 2000 .

[4]  J. Trauth,et al.  Public Attitudes Regarding Willingness to Participate in Medical Research Studies , 2000, Journal of health & social policy.

[5]  P M Ellis,et al.  Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  N Colabianchi,et al.  Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Kenneth N. Cissna,et al.  Patients' Perceptions of Physicians Communication and Outcomes of the Accrual to Trial Process , 2000, Health communication.

[8]  C. Coltman,et al.  Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.

[9]  R. Prescott,et al.  Barriers to participation in randomised controlled trials: a systematic review. , 1999, Journal of clinical epidemiology.

[10]  C. Klabunde,et al.  Factors influencing enrollment in clinical trials for cancer treatment. , 1999, Southern medical journal.

[11]  M. Coovert,et al.  Strategic physician communication and oncology clinical trials. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S. Vernon,et al.  The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial. , 1998, Preventive medicine.

[13]  L. Yoder,et al.  Expectations and experiences of patients with cancer participating in phase I clinical trials. , 1997, Oncology nursing forum.

[14]  B. Rimer,et al.  Participation in a women's breast cancer risk counseling trial: Who participates? Who declines? , 1996, Cancer.

[15]  B. Rimer,et al.  Recruiting high risk women into a breast cancer health promotion trial. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  Karl G. Jöreskog,et al.  Lisrel 8: Structural Equation Modeling With the Simplis Command Language , 1993 .

[17]  P. Engstrom,et al.  Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  S. Piantadosi,et al.  Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  P. Ganz.  Clinical trials. Concerns of the patient and the public , 1990 .

[20]  L. Siminoff,et al.  Doctor-patient communication about breast cancer adjuvant therapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  C Loehlin John,et al.  Latent variable models: an introduction to factor, path, and structural analysis , 1986 .

[22]  C L Soskolne,et al.  Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. , 1984, The New England journal of medicine.

[23]  D. J. Jackson,et al.  Factor Analysis and Measurement in Sociological Research. , 1983 .

[24]  E. Lusk,et al.  Attitudes toward clinical trials among patients and the public. , 1982, JAMA.

[25]  R. Prescott,et al.  Factors that limit the quality, number and progress of randomised controlled trials. , 1999, Health technology assessment.

[26]  Jon D. Miller,et al.  Public perceptions of science and technology : a comparative study of the European Union, the United States, Japan, and Canada , 1997 .

[27]  L. Siminoff,et al.  Offering the option of randomized clinical trials to cancer patients who overestimate their prognoses with standard therapies. , 1993, Cancer investigation.

[28]  C. Gotay,et al.  Accrual to cancer clinical trials: directions from the research literature. , 1991, Social science & medicine.